30-Month Stay Disputed In Endo’s Lidoderm Litigation With Mylan
Executive Summary
Endo’s lawsuit challenging the sufficiency of Mylan’s Paragraph IV notice was thrown out in its entirety. Mylan objects to Endo’s bid to amend its complaint, saying the brand company cannot now seek to invoke a 30-month stay.